CN106841640A - A kind of system that old human thrombomodulin is monitored by medical care platform - Google Patents
A kind of system that old human thrombomodulin is monitored by medical care platform Download PDFInfo
- Publication number
- CN106841640A CN106841640A CN201611184625.3A CN201611184625A CN106841640A CN 106841640 A CN106841640 A CN 106841640A CN 201611184625 A CN201611184625 A CN 201611184625A CN 106841640 A CN106841640 A CN 106841640A
- Authority
- CN
- China
- Prior art keywords
- thrombus
- optical signal
- chip
- change
- platform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 101000763314 Homo sapiens Thrombomodulin Proteins 0.000 title claims abstract description 11
- 102000051206 human THBD Human genes 0.000 title claims abstract description 11
- 208000007536 Thrombosis Diseases 0.000 claims abstract description 44
- 238000012544 monitoring process Methods 0.000 claims abstract description 24
- 230000003287 optical effect Effects 0.000 claims abstract description 19
- 238000001514 detection method Methods 0.000 claims abstract description 14
- 230000008859 change Effects 0.000 claims abstract description 12
- 210000004369 blood Anatomy 0.000 claims abstract description 10
- 239000008280 blood Substances 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 5
- 210000002381 plasma Anatomy 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 8
- 230000023555 blood coagulation Effects 0.000 claims description 5
- 230000002159 abnormal effect Effects 0.000 claims description 3
- 230000009466 transformation Effects 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 231100001015 blood dyscrasias Toxicity 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N35/00584—Control arrangements for automatic analysers
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses a kind of system that old human thrombomodulin is monitored by medical care platform, due to mainly including：Thrombus monitoring system is communicated by Ethernet and thrombus monitoring center platform, the thrombus monitoring system includes micro-fluidic detection chip, control chip and optical signal change-over circuit, micro-fluidic detection chip completes the hybrid reaction of blood plasma and reagent, the detection zone of micro-fluidic chip is passed through using light beam, optical signal is received in printing opacity opposite side, after optical signal change-over circuit, the optical signal of change is converted to the electric signal of change, the electric signal of conversion is sent to thrombus monitoring center platform by Ethernet under the control of control chip；Serious consequence is caused not in time to easily hair thrombosis patients blood supervision in the prior art such that it is able to overcome, realizes being monitored in time by the medical personnel of specialty, the disease hair to thrombus is prevented trouble before it happens.
Description
Technical field
The present invention relates to thrombus monitoring technical field, in particular it relates to a kind of monitor old human thrombomodulin by medical care platform
System.
Background technology
In the angiocarpy of live body, some visible components are separated out in blood generation solidification or blood, aggegation forms solid matter
The process of block, referred to as thrombosis.From unlike blood clot, thrombus is that in the state of blood flow, blood is in angiocarpy
The fritter that the surface of the exfoliation of systemic blood vessels inner face or mend is formed.Thrombus may come off, dynamic into lung along blood flow direction
Arteries and veins, triggers fatal pulmonary embolism, and fatal rate is high.
Today's society, the incidence of disease of thrombus rises year by year, and the situation for tending to occur thrombus cerebral infarction is very unexpected, and causes
There is hemiplegia or lethal in patient, does not also take effective monitoring method to easy hair crowd in the prior art, until there is disease
It is late during shape.
The content of the invention
It is an object of the present invention to regarding to the issue above, the system that old human thrombomodulin is monitored by medical care platform be proposed, with reality
Existing real-time monitoring blood, for blood dyscrasia, patient takes measures in time, it is to avoid thrombus produces irreversible injury to patient.
To achieve the above object, the technical solution adopted by the present invention is：It is a kind of that old human thrombomodulin is monitored by medical care platform
System, mainly includes：
Thrombus monitoring system and thrombus monitoring center platform, the thrombus monitoring system are put down by Ethernet with thrombus monitoring center
Platform is communicated, and the thrombus monitoring system includes micro-fluidic detection chip, control chip and optical signal change-over circuit, micro-fluidic
Detection chip completes the hybrid reaction of blood plasma and reagent, the detection zone of micro-fluidic chip is passed through using light beam, in printing opacity opposite side
Receive optical signal, through optical signal change-over circuit after, the optical signal of change is converted to the electric signal of change, in the control of control chip
The electric signal of conversion is sent to thrombus monitoring center platform by Ethernet under system.
Further, the control chip is dsp chip.
Further, the thrombus monitoring platform includes signal processing module and signal display module, respectively to reception
Electric signal is processed, and analysis blood clotting process is carried out image and shows, blood clotting process is analyzed by professional
Phase transformation difference, to abnormal blood patient in time notify take measures.
Further, the thrombus monitoring system also includes power supply, and system is powered.
A kind of system that old human thrombomodulin is monitored by medical care platform of various embodiments of the present invention, due to mainly including：Thrombus
Monitoring system is communicated by Ethernet and thrombus monitoring center platform, and the thrombus monitoring system includes micro-fluidic detection core
Piece, control chip and optical signal change-over circuit, micro-fluidic detection chip complete the hybrid reaction of blood plasma and reagent, saturating using light beam
Cross the detection zone of micro-fluidic chip, printing opacity opposite side receive optical signal, through optical signal change-over circuit after, will change optical signal
The electric signal of change is converted to, the electric signal of conversion is sent by Ethernet under the control of control chip into thrombus monitoring
Heart platform；Serious consequence is caused not in time to easily hair thrombosis patients blood supervision in the prior art such that it is able to overcome, realize by
The medical personnel of specialty are monitored in time, and the disease hair to thrombus is prevented trouble before it happens.
Other features and advantages of the present invention will be illustrated in the following description, also, the partly change from specification
Obtain it is clear that or being understood by implementing the present invention.
Below by embodiment, technical scheme is described in further detail.
Specific embodiment
Illustrated below in conjunction with to the preferred embodiments of the present invention, it will be appreciated that preferred embodiment described herein
It is merely to illustrate and explain the present invention, is not intended to limit the present invention.
Specifically, including thrombus monitoring system and thrombus monitoring center platform, the thrombus monitoring system passes through Ethernet
Communicated with thrombus monitoring center platform, the thrombus monitoring system includes micro-fluidic detection chip, control chip and light letter
Number change-over circuit, micro-fluidic detection chip completes the hybrid reaction of blood plasma and reagent, using light beam through micro-fluidic chip inspection
Survey area, printing opacity opposite side receive optical signal, through optical signal change-over circuit after, the optical signal of change is converted to the telecommunications of change
Number, the electric signal of conversion is sent to thrombus monitoring center platform by Ethernet under the control of control chip.
The control chip is dsp chip.
The thrombus monitoring platform includes signal processing module and signal display module, and the electric signal for receiving is carried out respectively
Process, and image carried out to analysis blood clotting process and show, the phase transformation difference of blood clotting process is analyzed by professional,
Abnormal blood patient is notified in time to take measures.
The thrombus monitoring system also includes power supply, and system is powered.
Following beneficial effect can at least be reached：The monitor in real time to patient is realized, is taken measures in time, prevented in not
So.
Finally it should be noted that：The preferred embodiments of the present invention are the foregoing is only, are not intended to limit the invention,
Although being described in detail to the present invention with reference to the foregoing embodiments, for a person skilled in the art, it still may be used
Modified with to the technical scheme described in foregoing embodiments, or equivalent is carried out to which part technical characteristic.
All any modification, equivalent substitution and improvements within the spirit and principles in the present invention, made etc., should be included in of the invention
Within protection domain.
Claims (4)
1. a kind of system that old human thrombomodulin is monitored by medical care platform, it is characterised in that supervised including thrombus monitoring system and thrombus
Measured center platform, the thrombus monitoring system is communicated by Ethernet and thrombus monitoring center platform, the thrombus monitoring
System includes micro-fluidic detection chip, control chip and optical signal change-over circuit, and micro-fluidic detection chip completes blood plasma and reagent
Hybrid reaction, using light beam through micro-fluidic chip detection zone, printing opacity opposite side receive optical signal, through optical signal change
After circuit, the optical signal of change is converted to the electric signal of change, passes through the electric signal of conversion under the control of control chip
Ethernet is sent to thrombus monitoring center platform.
2. the system of the old human thrombomodulin of medical care platform monitoring according to right described in require 1, it is characterised in that the control core
Piece is dsp chip.
3. the system that medical care platform according to claim 2 monitors old human thrombomodulin, it is characterised in that the thrombus monitoring
Platform includes signal processing module and signal display module, and the electric signal for receiving is processed respectively, and to analysis blood
Condensation process carries out image and shows, the phase transformation difference of blood clotting process is analyzed by professional, and to abnormal blood, patient is timely
Notice takes measures.
4. the system that medical care platform according to claim 3 monitors old human thrombomodulin, it is characterised in that the thrombus monitoring
System also includes power supply, and system is powered.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611184625.3A CN106841640A (en) | 2016-12-20 | 2016-12-20 | A kind of system that old human thrombomodulin is monitored by medical care platform |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611184625.3A CN106841640A (en) | 2016-12-20 | 2016-12-20 | A kind of system that old human thrombomodulin is monitored by medical care platform |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106841640A true CN106841640A (en) | 2017-06-13 |
Family
ID=59140780
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611184625.3A Pending CN106841640A (en) | 2016-12-20 | 2016-12-20 | A kind of system that old human thrombomodulin is monitored by medical care platform |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106841640A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1319808A (en) * | 2000-02-03 | 2001-10-31 | 姚亦鸣 | Medical health care system based on network structure |
| CN101658414A (en) * | 2009-06-19 | 2010-03-03 | 中卫莱康科技发展（北京）有限公司 | System and method for monitoring personal health |
| CN101708348A (en) * | 2009-12-10 | 2010-05-19 | 重庆山外山科技有限公司 | Blood purification system capable of being remotely monitored |
| WO2015102726A2 (en) * | 2013-10-16 | 2015-07-09 | President And Fellows Of Harvard College | A microfluidic device for real-time clinical monitoring and quantitative assessment of whole blood coagulation |
| CN105759066A (en) * | 2016-04-26 | 2016-07-13 | 绍兴普施康生物科技有限公司 | Full-automatic hemostasis examination analyzer and method |
-
2016
- 2016-12-20 CN CN201611184625.3A patent/CN106841640A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1319808A (en) * | 2000-02-03 | 2001-10-31 | 姚亦鸣 | Medical health care system based on network structure |
| CN101658414A (en) * | 2009-06-19 | 2010-03-03 | 中卫莱康科技发展（北京）有限公司 | System and method for monitoring personal health |
| CN101708348A (en) * | 2009-12-10 | 2010-05-19 | 重庆山外山科技有限公司 | Blood purification system capable of being remotely monitored |
| WO2015102726A2 (en) * | 2013-10-16 | 2015-07-09 | President And Fellows Of Harvard College | A microfluidic device for real-time clinical monitoring and quantitative assessment of whole blood coagulation |
| CN105759066A (en) * | 2016-04-26 | 2016-07-13 | 绍兴普施康生物科技有限公司 | Full-automatic hemostasis examination analyzer and method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2894396C (en) | A system and method to detect significant arrhythmic events through a photoplethysmogram (ppg) and accelerometer | |
| JPH11192217A (en) | Method and device for reducing artifact signal level in physiological signal | |
| LaRovere et al. | Transcranial Doppler sonography in pediatric neurocritical care: a review of clinical applications and case illustrations in the pediatric intensive care unit | |
| SG10201801189QA (en) | Method and system for detection of coronary artery disease in a person using a fusion approach | |
| Aletti et al. | Heart rate variability in children with cyanotic and acyanotic congenital heart disease: analysis by spectral and non linear indices | |
| RU2571891C1 (en) | Device for operator's attention control in man-machine systems | |
| Perez et al. | Cerebral oxygenation and processed EEG response to clamping and shunting during carotid endarterectomy under general anesthesia | |
| CN106841640A (en) | A kind of system that old human thrombomodulin is monitored by medical care platform | |
| CN103110404A (en) | Operating room anesthesia data monitoring method | |
| CN106725367A (en) | A kind of old human thrombomodulin monitoring system | |
| Rundo et al. | Deep neuro-vision embedded architecture for safety assessment in perceptive advanced driver assistance systems: the pedestrian tracking system use-case | |
| CN103156578A (en) | Intelligentized multi-parameter remote controller used for vital signs of patient in oxygen chamber | |
| Gulhane et al. | Intelligent fatigue detection and automatic vehicle control system | |
| CN109924957A (en) | A kind of radiationless sign monitoring method and system for premature | |
| CN106580260A (en) | An intelligent real-time detection system for mental patients' emotions | |
| CN203914889U (en) | Radiotherapy monitor system | |
| Mesibov | Facilitated communication: A warning for pediatric psychologists. | |
| Upadhyaya et al. | Lithium in prophylactic therapy of manic-depressive illness: Biochemical correlates of response. | |
| Aprigliano et al. | Pre-impact detection algorithm to identify lack of balance due to tripping-like perturbations | |
| HREBIEN et al. | Current and emerging technology in G-LOC detection: pulse wave delay for+ Gz tolerance assessment | |
| Klymenko et al. | On the question of hearing impairment in premature children who have experienced oxidative stress at birth | |
| XU et al. | The application of thyroid function tests in elderly patients with cardiovascular disease | |
| Walker et al. | Contextualising COVID-19 in 2024 | |
| Vijayalakshmi et al. | Analysis of Impacts of Various Masks on Human Health using IoT Device | |
| ZHANG et al. | Design and implementation of a fall detection system for elderly patients |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170613 |
|
| RJ01 | Rejection of invention patent application after publication |